Artificial Intelligence
Metamaterial Market is Expected to Grow at a CAGR of 21.74%, Reaching a Valuation of US$ 2058.89 Million from 2022-30 | Data by Contrive Datum Insights
Farmington, Jan. 26, 2023 (GLOBE NEWSWIRE) — The Metamaterial Market was worth USD 357.00 Million in 2022 and is expected to be worth USD 2058.89 Million by 2030, growing at a CAGR of 21.74% from 2023 to 2030. A metamaterial is an artificial substance with qualities that do not occur in nature. Multiple types of materials, such as metals, polymers, etc., are arranged in repeating patterns to create metamaterials. In contrast to natural composites, this one is manufactured in a laboratory and has a structure not found in nature. It possesses weird and unique features, such as electromagnetic properties.
Request Sample Copy of Report “Metamaterial Market – Global Industry Analysis, Size, Share, Growth Opportunities, Future Trends, Covid-19 Impact, SWOT Analysis, Competition and Forecasts 2022 to 2030”, published by Contrive Datum Insights.
The odd physical features of metamaterials, such as negative permittivity and permeability and negative index of refraction, have prompted extensive research and development. A metamaterial is significant because it can alter the propagation of electromagnetic or acoustic waves. This allows engineers to modify the propagation of waves by altering the construction of unit cells. With the advancement of technology, the increasing usage of consumer electronics, and the expansion of the telecommunications industry, the market for metamaterials is projected to have a rapid expansion in the next years.
Metamaterial Market Recent Developments:
- November 2020, Kymeta Corporation announces the availability of KymetaTM u8 and Kymeta ConnectTM for government and commercial purchases after November 30, 2020. This product helps companies meet their mobile communications needs by providing broadband satellite connectivity and cellular networks.
- In November 2020, Metamterial Technologies Inc. started selling directly through its online store. Initially, the company is selling the metaOPTIX family of holographic film notch filters.
- In October 2020, Echodyne Inc released the EchoGuard CR and RadarHub. The EchoGuard CR provides high performance, active beam steering, and 3D radar capabilities in urban and dense environments or locations with reduced range requirements. RadarHub simplifies the deployment and management of multiple radars.
Metamaterial Market Segmentation Analysis:
The market for metamaterials has been segmented into the electromagnetic, tunable, photonic, frequency-selective surface, terahertz, and other markets, each of which is based on a different type of material. The electromagnetic market contributed substantially to the total revenue in the year 2021. The structures that makeup metamaterials utilized in electromagnetic technology are, for the most part, manufactured with microwave and optical uses in mind. This is how metamaterials come to be used in this field. Additionally, countries in Asia-Pacific and the Middle East are devoting more resources to research on metamaterials, which is a significant contributor to the rising sales in this sector.
The global market for metamaterials can be broken down into several categories, such as absorbers, antennas, cloaking devices, super lenses, MRI, x-ray, and other markets, depending on how the materials are put to use. In 2021, the most money was made from the antenna section of the business. Antennas are gaining in popularity as a result of the shift toward nanotechnology that is occurring in the communication equipment industry, as well as the improvement that is occurring in Wi-Fi and communication satellite technology all over the world. Additionally, as digitalization expands in countries that are considered to be in the second or third world, an increase in the use of metamaterials is anticipated as a result of the increased interest in multiband antennas, which is driving the expansion of the market. This indicates that a greater amount of capital will be invested in the manufacturing of mobile phones.
Metamaterial Market Regional Outlook:
In 2021, the market for metamaterials was dominated by North America, which held a market share of 34.0% worldwide. The Asia-Pacific area and Europe finished in second and third, respectively, after the Americas. It is anticipated that the market for metamaterials would be most robust in Europe, followed by North America, during the course of the next few years. This is due to the fact that more money is being invested in research and development with the purpose of utilising metamaterials in a variety of various ways. For instance, in 2017, the Defense Advanced Research Projects Agency (DARPA), the United States Navy, and Lockheed Martin Corporation gave a combined total of US$ 8 million to Doug Werner, John L. McCain, and Genevieve H. McCain, chair professors in the Electrical Engineering department at Penn State, to assist them in their research on metamaterials. The market for metamaterials in the Asia-Pacific region is the one that is increasing at the fastest rate in terms of revenue.
During the period covered by the projection, it is anticipated that Europe would experience significant economic expansion. Several nations in Europe, such as France, Germany, and Sweden, are major hubs for the research and development of various medical devices that are used all over the world. The sector of health care is experiencing rapid expansion across Europe. The expansion of technology capabilities in the healthcare sector is driving growth in the metamaterials industry in Europe. For instance, metamaterials are currently being utilised in the diagnosis of life-threatening diseases like cancer, as well as in the enhancement of the quality of MRI (magnetic resonance imaging) and other imaging techniques used in medicine.
Buy this Premium Research Report@
https://www.contrivedatuminsights.com/buy/248379/?Mode=TM
Scope of Report:
| Report Attributes | Details |
| Growth Rate | 21.74% from 2023 to 2030 |
| Market Size in 2022 | USD 357.00 Million |
| Revenue Forecast by 2030 | USD 2058.89 Million |
| By Type | Electromagnetic Metamaterial, Frequency band Metamaterial, Terahertz metamaterial, Photonic Metamaterial, Tunable Metamaterial, Plasmonic metamaterial, Other |
| By Applications | Antenna, Solar panel, Sensors, Absorber, Medical Imaging, Superlens, Seismic protection, Sound filtering, Other |
| By Companies | Metamaterial Technologies Inc., Plasmonics, Inc., Kymeta Corporation, Phoebus Optoelectronics LLC, Multiwave Technologies AG, MetaShield LLC, Echodyne, Inc., Nano-Meta Technologies, Inc., JEM Engineering, and Acoustic Metamaterials Group, Ltd. |
| Base Year | 2022 |
| Historical Year | 2017 to 2021 |
| Forecast Year | 2023 to 2030 |
Metamaterial Market Dynamics:
Market Drivers:
Use of metamaterials in high-tech applications in aerospace, defence, and the military: For the military, aerospace, and defence industries to be able to communicate well, antenna technology needs to be improved. Communication that is reliable, efficient, and in real-time is essential for network-centric operations on the digital battlefield that needs to send accurate information to the right people. The antenna is an important part of defence, aerospace, and military systems that are sometimes overlooked.
Market Restraints
Infrastructure that isn’t good enough to make the products in large quantities: The big players in the industry still get most of their production from research universities. The structure of a metamaterial is what determines its properties, not the materials it is made of. So, metamaterials are made in different ways depending on how they will be used. Finding the right materials to meet the needs of an application can be hard. Because of this, making metamaterials is hard and takes a long time. Synthesis costs different amounts depending on the methods used to make it.
Market Opportunity:
5G’s progress: Antennas that use metamaterials will benefit from the development and use of 5G. People in the industry are working on creating Metamaterials that are based on antennas and could have good radiation patterns. This would make them great for more than just ultra-wideband applications and 5G communications.
Key Segments Covered:
Top Market Players:
Metamaterial Technologies Inc., Plasmonics, Inc., Kymeta Corporation, Phoebus Optoelectronics LLC, Multiwave Technologies AG, MetaShield LLC, Echodyne, Inc., Nano-Meta Technologies, Inc., JEM Engineering, and Acoustic Metamaterials Group, Ltd., among others., And Others.
By Material Type
- Electromagnetic Metamaterial
- Frequency band Metamaterial
- Terahertz metamaterial
- Photonic Metamaterial
- Tunable Metamaterial
- Plasmonic metamaterial
- Other
By Application
- Antenna
- Solar panel
- Sensors
- Absorber
- Medical Imaging
- Superlens
- Seismic protection
- Sound filtering
- Other
By End-Use Industry
- Aerospace & Defense
- Electronics & Telecommunication
- Automotive
- Power plants
- Medical
- Others
Regions and Countries Covered
- North America: (US, Canada, Mexico, Rest of North America)
- Europe: (Germany, France, Italy, Spain, UK, Nordic Countries, Benelux Union, Rest of Europe)
- Asia-Pacific: (Japan, China, India, Australia, South Korea, Southeast Asia, Rest of Asia-Pacific)
- The Middle East & Africa: (Saudi Arabia, UAE, Egypt, South Africa, Rest of the Middle East & Africa)
- Latin America: (Brazil, Argentina, Rest of Latin America)
- Rest Of the World
Check out more related studies published by Contrive Datum Insights:
- Solar Inverter Market – The Solar Inverter Market size was valued at USD 7.7 billion in 2022 and is expected to reach USD 17.9 billion by 2030, at a CAGR of 8.8% from 2022 to 2030. The Asia-Pacific region is expected to account for the largest revenue share at more than 44% during the forecast period. China is the largest contributor to the rapid growth of the solar market in the region and is a major competitor globally. Increasing solar installations in developing countries are also contributing to the growth of the market in this region has contributed significantly.
- Fiber Optic Sensors Market – The Fiber Optic Sensor Market Is Expected To Exceed USD 7.2 Billion By 2030, Growing At A CAGR Of 11.5% during the forecast period. In the European distributed fiber optic sensors market, Germany accounted for an 18.7% share in 2021. Germany is one of the largest consumers and manufacturers of military equipment in Europe.
- Nuclear Medicine Imaging Equipment Market – The Global Nuclear Medicine Imaging Equipment Market Is Expected To Grow From USD 2.8 Billion In 2022 And CAGR Of Approximately 4.9% During The Forecast Period 2022-2030. North America will dominate the market with a share of 45.2% in 2021 and is expected to grow at a significant rate during the forecast period. The high market share in the region can be attributed to increasing investments in R&D activities, high usage of nuclear medicine procedures, and strong healthcare infrastructure.
- Distributed Antenna System (Das) Market – The Distributed Antenna Systems (DAS) market was valued at USD 10.04 billion in 2022 and is expected to reach USD 19.84 billion by 2030, at a CAGR of 12.10% over the forecast period 2022 – 2030. North America is expected to be the largest DAS market during the forecast period. It is one of the most technologically advanced regions in the world. Consumers in the region have readily adopted 4G-capable smartphones, making the region one of the world’s most mobile densely populated regions.
Customization of the Report: The report can be customized as per client needs or requirements.For any queries, you can contact us at [email protected] or +1 215-297-4078. Our sales executives will be happy to understand your needs and provide you with the most suitable reports.
About Us:
Contrive Datum Insights (CDI) is a global delivery partner of market intelligence and consulting services to officials at various sectors such as investment, information technology, telecommunication, consumer technology, and manufacturing markets. CDI assists investment communities, business executives, and IT professionals to undertake statistics-based accurate decisions on technology purchases and advance strong growth tactics to sustain market competitiveness. Comprising of a team size of more than 100 analysts and cumulative market experience of more than 200 years, Contrive Datum Insights guarantees the delivery of industry knowledge combined with global and country-level expertise.
Social: Facebook / LinkedIn / Twitter
Contact Us:
Anna B. | Head Of Sales
Contrive Datum Insights
Phone: +91 9834816757 | +1 2152974078
Email: [email protected]
Website:
https://www.contrivedatuminsights.com
Contrive Datum Insights Press Releases
Latest Contrive Datum Insights Latest Reports
USA News Group Commentary
VANCOUVER, BC, April 25, 2024 /PRNewswire/ — Across several sectors the use of artificial intelligence (AI) is making a huge impact, with healthcare emerging as possibly receiving the largest boost. According to a new research report from analysts at Mordor Intelligence, the market for artificial intelligence in health care is set to explode at a CAGR of 42.20% through 2029. As the tech sector races to provide the market with solutions, several companies are emerging as leaders in aiding the healthcare sector, including Avant Technologies Inc. (OTC:AVAI), Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT), Health Catalyst, Inc. (NASDAQ:HCAT), Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), and Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX).
Recently, Avant Technologies Inc. (OTC:AVAI) strengthened its AI-powered healthcare offerings by acquiring Wired-4-Health, a company specializing in healthcare technology and data services. This addition supports Avant’s goal to create the first supercomputing network in the country. This network will offer big data and AI software companies a quicker, more potent, and more affordable computing infrastructure.
“Our strategy behind this acquisition was to enable Avant to deliver best-in-class data and system interoperability support services to the healthcare and life sciences sectors powered by AvantAI® and our high-density compute capabilities,” said Tim Lantz, CEO of Avant Technologies. “At the same time, this exciting combination significantly strengthens our financial profile, offers massive commercial growth opportunities in one of Avant’s largest target markets, and bolsters our internal customer support and R&D capabilities.”
The goal of this deal is to bring together Avant Technologies and Wired-4-Health to improve how healthcare data is shared and used. By joining forces, they can use advanced AI and powerful computing to help healthcare and life sciences organizations deal with data and system challenges more easily and effectively.
This partnership improves the way transactions are processed, analyzes health outcomes, and ensures compliance, leading to better performance, more reliable data, and a more affordable, scalable system for customers.
“In the near term, if the healthcare industry expects to succeed in lowering costs while improving quality, the deployment of advanced AI, combined with more powerful, cost- effective compute capabilities will be critical to that success,” said Angela Harris, Avant’s Chief Operating Officer. “The addition of Wired-4-Health will position Avant as a key contributor in helping healthcare organizations solve complex problems at the intersection of cost, quality, compliance and technology.”
Tech giant Microsoft Corporation (NASDAQ:MSFT) (NEO:MSFT) has also been aiding the healthcare sector, most notably with its Azure AI Health Bot, which helps create copilot experiences with healthcare safeguards. Microsoft is enhancing its Azure AI Health Bot services by adding new healthcare-specific safeguards and features, including integration with Microsoft Copilot Studio.
These upgrades allow healthcare organizations to create their own copilot experiences, with pre-built capabilities, templates, and connectors tailored to healthcare needs, supporting protocol-based workflows alongside AI-based answers, and ensuring compliance with industry standards and guidelines. Now the platform is already being put into use by big players, including by German pharma giant Roche.
“By leveraging Azure AI Health Bot to build copilot experiences for doctors, we are developing an intuitive, conversational interface that lets clinicians access and explore Roche’s clinical documentations in a more natural way and to cope with the complexity and flood of information,” said Dr. Georg Isbary of Roche Pharma Germany. “The pilot for this new user experience, powered by generative AI features and compliant with the necessary security standards, has been integrated into our systems and will be further tailored to regional market needs.”
Long-time developer in the AI and machine learning (ML) space for healthcare, Health Catalyst, Inc. (NASDAQ:HCAT) signed a multi-year partnership with SacValley MedShare, one of California’s largest and most established qualified health information organization, earlier this year. As per the deal, Health Catalyst will support SacValley’s important mission through a broad set of technology solutions, including KPI Ninja by Health Catalyst, Healthcare.AI – a Health Catalyst Data Operating System (DOSTM) Platform module, and several other application solutions and Professional Services.
“We are honored to partner with SacValley MedShare on their continued journey to advance healthcare and are confident our technology, combined with our dedicated, skilled team members, will deliver the improved efficiency and support SacValley MedShare needs to achieve its healthcare transformation goals,” said Dan Burton, CEO of Health Catalyst.
By choosing Health Catalyst’s advanced data and analytics services, SacValley will enhance its ability to share and use information. This will lead to better service for those paying for healthcare, by making it easier to share important health details. This helps in delivering top-notch reports and care for patients.
“Transforming data from movable to usable is the alchemy of insights, turning raw potential into the gold of informed decision-making, ultimately forging a path towards health equity and improved outcomes,” said John Helvey, Executive Director of SacValley MedShare. “This is the primary reason SVMS chose Health Catalyst as a transforming partner.”
Another AI player is Ginkgo Bioworks Holdings, Inc. (NYSE:DNA), which is making it easier and cheaper for other biopharma companies to produce important biological materials and organisms by using artificial intelligence (AI). Back in February 2024, Ginkgo announced the acquisition of key assets of Reverie Labs, which has built and used AI/ML tools to accelerate drug discovery. The acquisition of Reverie’s infrastructure and software serves to help train large-scale AI foundation models, while four of Reverie’s key AI team members will also be joining Ginkgo.
Gingko followed this up through a collaboration with UK-based biotech company Prozomix, to build out the production of next generation enzyme plates for active pharmaceutical ingredient (API) manufacturing. The agreement aims to leverage Gingko’s Enzyme Services and industry-leading AI/ML models along with Prozomix’s existing enzyme libraries and deep experience manufacturing enzyme plates.
“API manufacturing is poised to greatly benefit from the latest in enzyme engineering and AI/ML enzyme models,” said Cindy Chang, Senior Director, Business Development at Ginkgo Bioworks. “We are so excited to partner with Prozomix to get enzymes into as many API routes as possible and help partners meet both their COGs savings and sustainability goals.”
Another developer helping to lead the way in AI-powered healthcare is Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX), which uses AI to pick out which treatments should be tested in clinical trials, while also letting biopharma companies to use their AI tools to do so also.
Last year, Recursion lined up a $50-million collaboration with AI chipmaking giant Nvidia for AI drug discovery. Then at the beginning of 2024, Recursion presented a demonstration of LOWE (Large Language Model-Orchestrated Workflow Engine), a new software designed to perform complex drug discovery tasks using a natural language interface. The platform is powered by Recursion’s proprietary biological and chemical data, and can orchestrate experiments using Recursion’s automated wet laboratories, unleashing the power of the Recursion Operating System in an easy-to-use tool.
“For the first time, we’ve taught Large Language Models to use many of Recursion’s tools and data in the same way an expert scientist would, but much more simply and in a more scalable way,” said Chris Gibson, Ph.D., Co-founder and CEO of Recursion. “LOWE provides an exciting glimpse into what we believe the future of drug discovery will look like – a first step towards the development of autonomous ‘AI scientists’ for therapeutic discovery.”
Source: https://usanewsgroup.com/2023/10/26/unlocking-the-trillion-dollar-ai-market-what-investors-need-to-know/
CONTACT:USA News [email protected]
DISCLAIMER: Nothing in this publication should be considered as personalized financial advice. We are not licensed under securities laws to address your particular financial situation. No communication by our employees to you should be deemed as personalized financial advice. Please consult a licensed financial advisor before making any investment decision. This is a paid advertisement and is neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this report or email is not provided to any individual with a view toward their individual circumstances. USA News Group is a wholly-owned subsidiary of Market IQ Media Group, Inc. (“MIQ”). MIQ has been paid a fee for Avant Technologies Inc. advertising and digital media from the company directly. There may be 3rd parties who may have shares Avant Technologies Inc., and may liquidate their shares which could have a negative effect on the price of the stock. This compensation constitutes a conflict of interest as to our ability to remain objective in our communication regarding the profiled company. Because of this conflict, individuals are strongly encouraged to not use this publication as the basis for any investment decision. The owner/operator of MIQ own shares of Avant Technologies Inc. which were purchased as a part of a private placement. MIQ reserves the right to buy and sell, and will buy and sell shares of Avant Technologies Inc. at any time thereafter without any further notice. We also expect further compensation as an ongoing digital media effort to increase visibility for the company, no further notice will be given, but let this disclaimer serve as notice that all material disseminated by MIQ has been approved by the above mentioned company; this is a paid advertisement, and we own shares of the mentioned company that we will sell, and we also reserve the right to buy shares of the company in the open market, or through further private placements and/or investment vehicles. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions and actual results. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.
View original content:https://www.prnewswire.co.uk/news-releases/ai-in-healthcare-unveiling-the-future-with-a-42-20-cagr-through-2029–302127335.html
Artificial Intelligence
Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
SAN DIEGO and CALGARY, AB, April 25, 2024 /PRNewswire/ — Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for oncology, today announced the acceptance of two abstracts at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting, which is taking place from May 31 – June 4, 2024, in Chicago, Illinois. Details on the abstracts and poster presentation are shown below.
Title: Phase 1/2 randomized, open-label, multicenter, Simon two-stage study of pelareorep combined with modified FOLFIRINOX +/- atezolizumab in patients with metastatic pancreatic ductal adenocarcinoma.
Presentation Type: PosterAbstract Number: TPS4203Session Title: Gastrointestinal Cancer – Gastroesophageal, Pancreatic, and HepatobiliarySession Date and Time: June 1, 2024, 1:30 – 4:30 p.m. CTTitle: Pelareorep driven blood TIL expansion in patients with pancreatic, breast and colon cancer.Presentation Type: Online abstractAbstract Number: e14625
Abstracts will be published on the ASCO Annual Meeting website at 5:00 p.m. ET on May 23, 2024.
About Oncolytics Biotech Inc.
Oncolytics is a clinical-stage biotechnology company developing pelareorep, an intravenously delivered immunotherapeutic agent. Pelareorep has demonstrated promising results in two randomized Phase 2 studies in metastatic breast cancer and Phase 1 and 2 studies in pancreatic cancer. It acts by inducing anti-cancer immune responses and promotes an inflamed tumor phenotype — turning “cold” tumors “hot” — through innate and adaptive immune responses to treat a variety of cancers.
Pelareorep has demonstrated synergies with multiple approved oncology treatments. Oncolytics is currently conducting and planning combination clinical trials with pelareorep in solid and hematological malignancies as it advances towards registrational studies in metastatic breast cancer and pancreatic cancer, both of which have received Fast Track designation from the FDA. For further information, please visit: www.oncolyticsbiotech.com or follow the company on social media on LinkedIn and on X @oncolytics.
Company Contact
Jon Patton
Director of IR & Communication
[email protected]
Investor Relations for Oncolytics
Timothy McCarthy
LifeSci Advisors
+1-917-679-9282
[email protected]
View original content:https://www.prnewswire.co.uk/news-releases/oncolytics-biotech-announces-upcoming-presentations-at-the-american-society-of-clinical-oncology-annual-meeting-302127245.html
Artificial Intelligence
Internet of Things (IoT) Market to Expand at a Stellar 19.4% CAGR through 2031 | SkyQuest Technology
WESTFORD, Mass., April 25, 2024 /PRNewswire/ — SkyQuest projects that the Internet of Things (IoT) Market will attain a value of USD 1572.37 billion by 2031, with a CAGR of 19.4% over the forecast period (2024-2031). Internet of Things (IoT) refers to the network of connected devices over the internet that are embedded with sensors and software. Growing adoption of automation around the world and advancements in connected device technologies are forecasted to be key factors driving the Internet of Things (IoT) market growth in the future.
Download a detailed overview:
https://www.skyquestt.com/report/internet-of-things-market
Browse in-depth TOC on “Internet of Things (IoT) Market”
Pages – 197Tables – 69Figures – 75Internet of Things (IoT) Market Overview:
Report Coverage
Details
Market Revenue in 2023
$ 380.6 billion
Estimated Value by 2031
$1572.37 billion
Growth Rate
Poised to grow at a CAGR of 19.4%
Forecast Period
2024–2031
Forecast Units
Value (USD Billion)
Report Coverage
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Segments Covered
Component Type, Application, and Region
Geographies Covered
North America, Europe, Asia Pacific, and the Rest of the world
Report Highlights
Updated financial information / product portfolio of players
Key Market Opportunities
Rising demand for connected healthcare and growing use of industrial automation solutions
Key Market Drivers
Advancements in connectivity and connected device technologies
Hardware is Estimated to Dominate the Global Market Share Owing to High Use of Hardware Components in IoT
Hardware components such as sensors and actuators are highly vital to the proper functioning of any kind of Internet of Things (IoT) device. Growing adoption of IoT devices in different industry verticals for various applications is promoting market growth via this segment. The development of new hardware solutions also helps this segment maintain its dominance.
Smart Agriculture is the Fastest-growing Segment Owing to Rising Adoption of Precision Agriculture Practice
Rising emphasis on improving agricultural yield and sustainability has resulted in the growing adoption of smart agriculture and precision agriculture practices. IoT devices play a crucial role in monitoring and controlling different elements of a smart agriculture setup that is mostly automated using different smart devices thereby contributing to the IoT market growth as well.
Growing Adoption of 5G Technology Allowing North America to Dominate the Global Internet of Things (IoT) Market
Rapid adoption of 5G technology and high use of cloud-based platforms are key factors allowing North America to lead the demand for Internet of Things (IoT) around the world. Surging investments in the research and development of advanced technologies and the presence of key tech giants such as Amazon, Google, IBM, and Microsoft also helps the dominance of this region. Canada and the United States remain the most lucrative markets for Internet of Things (IoT) companies in North America through 2031.
Request Free Customization of this report:
https://www.skyquestt.com/speak-with-analyst/internet-of-things-market
Internet of Things (IoT) Market Insights:
Drivers
Advancements in connectivity and connected device technologies.Growing demand for Industrial IoT (IIoT) solutions.Increasing number of smart cities and development of smart infrastructure.Restraints
Lack of standardization of IoT devices and technologies.Privacy and data security issues.Interoperability challenges and complex integration scenarios.Prominent Players in Internet of Things (IoT) Market
MicrosoftCisco SystemsIntelSiemens (Germany)AWS (US)Oracle (US)Qualcomm (UK)SAP (Germany)IBM (US)Google (US)View report summary and Table of Contents (TOC):
https://www.skyquestt.com/report/internet-of-things-market
Key Questions Answered in Internet of Things (IoT) Market Report
What are the top drivers for Internet of Things (IoT) market going forward?Who are the leading Internet of Things (IoT) market players?Where will demand for Internet of Things (IoT) be high?Which component accounts for a dominant revenue share of the global Internet of Things (IoT) market?This report provides the following insights:
Analysis of key drivers (advancements in connectivity and connected device technologies, growing demand for industrial IoT (IIoT), development of smart infrastructure for smart cities, growing use of smart devices ), restraints (lack of standardization, complexities in integration, concerns regarding security and privacy of data), and opportunities (rising popularity of connected healthcare, increasing adoption of Industry 4.0, rising use of industrial automation), influencing the growth of Internet of Things (IoT) market.Market Penetration: All-inclusive analysis of product portfolio of different market players and status of new product launches.Product Development/Innovation: Elaborate assessment of R&D activities, new product development, and upcoming trends of the Internet of Things (IoT) market.Market Development: Detailed analysis of potential regions where the market has potential to grow.Market Diversification: Comprehensive assessment of new product launches, recent developments, and emerging regional markets.Competitive Landscape: Detailed analysis of growth strategies, revenue analysis, and product innovation by new and established market players.Related Reports:
Global Internet of Things in Retail Market
Global Internet of Things (IoT) in Agriculture Market
Global Internet of Things (IoT) Microcontroller Market
Global IOT In Healthcare Market
Global IOT in Manufacturing Market
About Us:
SkyQuest is an IP focused Research and Investment Bank and Accelerator of Technology and assets. We provide access to technologies, markets and finance across sectors viz. Life Sciences, CleanTech, AgriTech, NanoTech and Information & Communication Technology.
We work closely with innovators, inventors, innovation seekers, entrepreneurs, companies and investors alike in leveraging external sources of R&D. Moreover, we help them in optimizing the economic potential of their intellectual assets. Our experiences with innovation management and commercialization has expanded our reach across North America, Europe, ASEAN and Asia Pacific.
Contact:
Mr. Jagraj Singh Skyquest Technology1 Apache Way,Westford,Massachusetts 01886USA (+1) 351-333-4748Email: [email protected] Our Website: https://www.skyquestt.com/
View original content:https://www.prnewswire.co.uk/news-releases/internet-of-things-iot-market-to-expand-at-a-stellar-19-4-cagr-through-2031–skyquest-technology-302127239.html
-
Uncategorized6 days agoGenerative AI gold rush drives IT spending — with payoff in question
-
Uncategorized6 days ago
Do underwriters trust artificial intelligence?
-
Uncategorized6 days ago
Hans Jonas on Responsibility in the Age of Artificial Intelligence
-
Uncategorized6 days ago
Meta AI Assistant Adds Website, Expands Beyond US
-
Artificial Intelligence6 days agoFree Your Hands, QIDI Vida Smart AR Glasses Lead the Way in New Sports Experience.
-
Uncategorized6 days ago
Can artificial intelligence reduce vehicle time to market?
-
Artificial Intelligence5 days agoAurionpro Solutions acquires Arya.ai, to power next generation Enterprise AI platforms for Financial Institutions
-
Uncategorized6 days ago
The Ottawa Hospital doctors to try AI for patient notes
